NASDAQ : CLBT
-$0.39 (-2.46%)
| Source | Headline |
|---|---|
|
Cellebrite CEO Thomas Hogan Sells 103,000 Shares for $1.6 Million: Is This a Concern for Investors?
Hogan's non-discretionary sale satisfied tax withholding obligations from vesting RSUs. He retains 590,777 shares worth $9.25 million. fool.com - 2026-07-14 12:16:10 |
|
Cellebrite Expands Exclusive SkySafe Partnership to Deliver Immediate Drone Detection and Airspace Intelligence for Digital Investigations at Scale
The partnership unifies what happens in the sky with what's stored on the drone in a single investigative workflow TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 8, 2026 /PRNewswire/ -- Cellebrite DI Ltd. prnewswire.com - 2026-07-08 08:30:00 |
|
Cellebrite: Stronger Fundamentals Support A Buy Rating
Cellebrite (CLBT) remains a buy as fundamentals strengthen, with FedRAMP High achieved and federal demand reaccelerating. Q2 ARR guidance of $510–513M implies 22–23% growth, supporting a narrative of renewed momentum post-federal softness. Platform adoption advances, with Inseyets conversions near 60% and growth products now 14% of ARR, lengthening CLBT's growth runway. seekingalpha.com - 2026-06-12 11:41:03 |
|
Cellebrite DI Ltd. (CLBT) Discusses AI Technology and Innovation in Tech Talk Transcript
Cellebrite DI Ltd. (CLBT) Discusses AI Technology and Innovation in Tech Talk Transcript seekingalpha.com - 2026-06-10 13:02:15 |
|
Cellebrite Launches the New Age of Investigations with Genesis, Now Generally Available
Reduces investigative workloads from weeks to minutes accelerating investigations like never before TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 10, 2026 /PRNewswire/ -- Cellebrite DI Ltd. prnewswire.com - 2026-06-10 08:30:00 |
|
Cellebrite kündigt bevorstehende Investorenveranstaltungen am 10. Juni 2026 an
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und prnewswire.com - 2026-06-05 12:51:00 |
|
Cellebrite Announces Upcoming Investor Events on June 10, 2026
Cellebrite Announces Upcoming Investor Events on June 10, 2026 PR Newswire TYSONS CORNER, Va. and PETAH TIKVA, I gurufocus.com - 2026-06-05 09:00:00 |
|
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market
Credo, Cellebrite, and TransMedics are building dominant positions in huge markets with years of expansion still ahead. fool.com - 2026-06-05 08:20:00 |
|
Cellebrite Announces Upcoming Investor Events on June 10, 2026
TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 5, 2026 /PRNewswire/ -- Cellebrite DI Ltd. prnewswire.com - 2026-06-05 08:00:00 |
|
Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows
Cellebrite DI NASDAQ: CLBT executives said the company is seeing broader customer adoption of its digital investigations platform, with artificial intelligence, cloud migration and U.S. federal authorization expected to shape its next phase of growth. marketbeat.com - 2026-05-28 03:04:27 |
|
CGNT vs. CLBT: Which Intelligence Software Stock Offers Better Upside?
Cognyte and Cellebrite are riding AI-driven investigative demand - dig into their growth, profitability, valuation and risks to see which offers better upside. zacks.com - 2026-05-25 11:46:05 |
|
Cellebrite DI Sees Federal Rebound as AI, Defense Tools Fuel New Growth
Cellebrite DI NASDAQ: CLBT executives said the digital investigations company is seeing renewed momentum in government demand, international markets and new product categories, including artificial intelligence and defense-focused capabilities, during a JPMorgan cybersecurity and DevOps event hosted by analyst Brian Essex. marketbeat.com - 2026-05-18 23:04:37 |
|
Cellebrite DI Ltd. (CLBT) Presents at J.P.
Cellebrite DI Ltd. (CLBT) Presents at J.P. seekingalpha.com - 2026-05-18 17:10:46 |
|
Cellebrite: Positive Q1 Results, But There Is Room For Margin Improvements
Cellebrite delivered strong Q1 2026 results, with 19% revenue growth and notable subscription and ARR gains, beating analyst expectations. CLBT expanded its portfolio with the SCG Canada acquisition and launched AI-powered solutions, positioning itself for long-term growth and broader market reach. Despite robust top-line growth, gross, operating, and net margins declined; margin expansion remains a key area to monitor. seekingalpha.com - 2026-05-16 08:45:09 |
|
Cellebrite DI Ltd. (CLBT) Q1 2026 Earnings Call Transcript
Cellebrite DI Ltd. (CLBT) Q1 2026 Earnings Call Transcript seekingalpha.com - 2026-05-14 16:20:46 |
|
Cellebrite DI Q1 Earnings Call Highlights
Cellebrite DI NASDAQ: CLBT reported first-quarter 2026 results that management said met or exceeded the high end of its guidance for annual recurring revenue and adjusted EBITDA, while executives highlighted a wave of new product launches centered on artificial intelligence, cloud-based case management and mobile device access. marketbeat.com - 2026-05-14 10:09:32 |
|
Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Top Estimates
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.11 per share. zacks.com - 2026-05-14 09:21:15 |
|
Cellebrite Announces First-Quarter 2026 Results
First-Quarter ARR Growth of 21% and TTM Free Cash Flow Margin of 32% Q2 Outlook Highlights ARR Acceleration TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 14, 2026 /PRNewswire/ -- Cellebrite DI Ltd. prnewswire.com - 2026-05-14 07:00:00 |
|
Breakfast News: Alphabet Surge Brings Bubble Fears
Alphabet vies for biggest company spot, markets post another record week, and more fool.com - 2026-05-11 07:30:00 |
|
Cellebrite Announces Participation in Upcoming Investor Conferences
TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 8, 2026 /PRNewswire/ -- Cellebrite DI Ltd. prnewswire.com - 2026-05-08 08:30:00 |
|
Cellebrite Government Cloud logra la autorización de alto nivel de FedRAMP
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), líder mundial en soluciones de inteligencia e investigación digital basadas en IA para los sectores público prnewswire.com - 2026-05-06 11:24:00 |
|
Cellebrite Government Cloud Achieves FedRAMP High Authorization
Authorization at the highest security standard in the FedRAMP framework enables federal government examiners, investigators, intelligence analysts and field agents to securely collaborate and act on digital evidence TYSONS CORNER, Va., May 6, 2026 /PRNewswire/ -- Cellebrite DI Ltd. prnewswire.com - 2026-05-06 08:30:00 |
|
Cellebrite: Is This Stock Worth the Investment?
Explore the exciting world of Cellebrite (CLBT +2.69%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities! fool.com - 2026-05-01 19:00:00 |
|
Shiven Ramji, ehemaliger Vorsitzender von Auth0 bei Okta, wechselt als Produkt- und Technologievorstand zu Cellebrite
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und prnewswire.com - 2026-05-01 00:35:00 |
|
Shiven Ramji, ancien président d'Auth0 chez Okta, rejoint Cellebrite en tant que président chargé des produits et de la technologie
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), leader mondial des solutions d'enquête et de renseignement numériques alimentées par l'IA, a annoncé prnewswire.com - 2026-05-01 00:27:00 |
|
Shiven Ramji, expresidente de Okta y Auth0, se unirá a Cellebrite como presidente de Productos y Tecnología
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), líder mundial en soluciones de inteligencia e investigación digital basadas en IA, anunció hoy el prnewswire.com - 2026-04-30 15:15:00 |
|
Former Okta President of Auth0, Shiven Ramji, to Join Cellebrite as President, Products and Technology
Ronnen Armon to Retire TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 30, 2026 /PRNewswire/ -- Cellebrite DI Ltd. prnewswire.com - 2026-04-30 09:00:00 |
|
Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of Cellebrite DI Ltd. (NASDAQ: CLBT - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the five analysts that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average 12 defenseworld.net - 2026-04-27 02:38:48 |
|
Cellebrite to Report First-Quarter 2026 Financial Results on May 14, 2026
TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 21, 2026 /PRNewswire/ -- Cellebrite DI Ltd. prnewswire.com - 2026-04-21 08:30:00 |